Is axonis.us Safe? Security Analysis for Axonis Therapeutics, Inc.
https://axonis.usCheck if axonis.us is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for axonis.us
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Axonis Therapeutics, Inc. is a Boston-based biotechnology company specializing in neuro-focused drug development targeting KCC2, a key protein involved in neuronal inhibition. The company leverages proprietary technology spun out from leading academic institutions and has secured significant Series A funding to advance its first-in-class oral KCC2 potentiator drug, AXN-027, aimed at treating epilepsy, pain, and other CNS disorders. The website reflects a professional and focused business presence with clear scientific and investment messaging. Technically, the website is built on WordPress using Elementor and Astra theme, with modern web technologies and SEO optimizations in place. The site is mobile-optimized and performs moderately well, though some accessibility features could be improved. Security posture is adequate with HTTPS enforced and domain protections, but lacks advanced security headers and DNSSEC. No direct contact emails or phone numbers are published; contact is via a form. Privacy and cookie policies are minimal, with only an FCOI policy found. No incident response or vulnerability disclosure information is provided, indicating room for improvement in transparency and compliance. Overall, the website presents a credible and professional biotech company with solid business and technical foundations but could enhance security and privacy compliance to strengthen trust and regulatory adherence.
Detected Technologies
14 urgent findings need attention
14 high
- + 6 more findings in the full report below
Keep axonis.us under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
8 findings
15/100
GDPR Compliance
4 findings
35/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
85/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Axonis Therapeutics positions itself as an emerging leader in the neuropharmaceutical space, focusing on KCC2-targeted therapies. The company benefits from strong academic roots and substantial venture funding, indicating growth potential. Its business model centers on drug discovery and clinical development for neurological disorders, targeting markets such as epilepsy and pain management. The website content and structure support investor relations and scientific credibility, though direct customer engagement channels are limited. The LinkedIn presence supports professional networking. No partnerships or subsidiaries are explicitly mentioned, suggesting a focused standalone operation. The company’s recent $115 million Series A financing and planned clinical trials in 2024 highlight active development and market entry efforts. The absence of detailed privacy and security policies may reflect early-stage digital maturity in compliance areas.
Security Posture Analysis
Comprehensive Security Assessment
The website enforces HTTPS with a valid SSL certificate, ensuring encrypted communications. Domain registration includes multiple EPP status protections, reducing risk of unauthorized transfers or deletions. However, the absence of DNSSEC leaves the domain vulnerable to DNS spoofing attacks. No HTTP security headers such as Content-Security-Policy, X-Frame-Options, or Strict-Transport-Security were detected, which are recommended to mitigate common web attacks. No explicit security or incident response policies are published, and no security.txt or vulnerability disclosure mechanisms are present, limiting transparency and readiness for security incidents. The contact methods do not include dedicated security or abuse channels. The site uses common third-party libraries (jQuery, FontAwesome) without detected vulnerabilities but should maintain updates. Overall, the security posture is moderate but could be significantly improved by implementing recommended headers, DNSSEC, and publishing security policies to enhance trust and compliance.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and publish a comprehensive privacy policy and cookie consent mechanism to improve GDPR compliance.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Axonis Therapeutics, Inc.
Axonis Therapeutics is a Boston-based biotechnology company developing first- and best-in-class neuromedicines targeting KCC2, the critical mediator of inhibition within the brain. They translate breakthrough discoveries from Boston Children’s Hospital, Harvard, and Laval University. They recently closed a $115 million Series A financing and plan first-in-human trials in 2024 for AXN-027, an oral KCC2 potentiator drug for epilepsy, pain, and other CNS pathologies.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Domain status includes clientDeleteProhibited and other EPP protections
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is professionally designed and content-rich for a biotech company.
Get this report delivered to your inbox
Receive a summary of the axonis.us security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Third-party services without privacy policy
HIGHDetected services: Google Analytics, LinkedIn, Google APIs
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, banking, health, digital
Need this report as a PDF?
Download the complete axonis.us security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 78 days
Weak SSL Key Length
HIGHSSL certificate uses 256-bit key, which is considered weak
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does axonis.us compare?
See how axonis.us stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the axonis.us report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the axonis.us report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about axonis.us
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published